Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Basel Medical (BMGL) Liabilities and Shareholders Equity (2024 - 2025)

Historic Liabilities and Shareholders Equity for Basel Medical (BMGL) over the last 2 years, with Q2 2025 value amounting to $12.9 million.

  • Basel Medical's Liabilities and Shareholders Equity rose 742.0% to $12.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $36.2 million, marking a year-over-year change of. This contributed to the annual value of $12.7 million for FY2025, which is 553.49% up from last year.
  • Basel Medical's Liabilities and Shareholders Equity amounted to $12.9 million in Q2 2025, which was up 742.0% from $11.2 million recorded in Q4 2024.
  • In the past 5 years, Basel Medical's Liabilities and Shareholders Equity registered a high of $12.9 million during Q2 2025, and its lowest value of $11.2 million during Q4 2024.